UK markets open in 2 hours 50 minutes

Oxford BioDynamics Plc (OBD.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
41.00-6.00 (-12.77%)
At close: 06:26PM BST

Oxford BioDynamics Plc

3140 Rowan Place
John Smith Drive Oxford Business Park South
Oxford OX4 2WB
United Kingdom
44 1865 518 910

Full-time employees43

Key executives

NameTitlePayExercisedYear born
Dr. Jon Anthony Joseph Burrows B.Sc., M.Sc., Ph.D.CEO & Exec. Director540kN/A1963
Mr. Paul Leslie Stockdale F.C.A., M.A.CFO & Exec. Director205.97kN/A1975
Dr. Alexandre Akoulitchev M.A., Ma (Oxon), Ph.D.Chief Scientific Officer & Exec. Director229.45kN/A1962
Mr. Thomas G. Guiel B.A.Chief Operating OfficerN/AN/AN/A
Dr. Ewan Hunter B.Sc., BSC, Ph.D., Ph.D., (KCL)Chief Data OfficerN/AN/AN/A
T. DemainCompany Sec.N/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.


Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients. Its products include EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.

Corporate governance

Oxford BioDynamics Plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.